BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26982434)

  • 1. Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.
    de Oliveira LH; Trumbo SP; Ruiz Matus C; Sanwogou NJ; Toscano CM
    Expert Rev Vaccines; 2016 Oct; 15(10):1295-304. PubMed ID: 26982434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From global to regional: the importance of pneumococcal disease in Latin America.
    de Quadros CA
    Vaccine; 2009 Aug; 27 Suppl 3():C29-32. PubMed ID: 19540025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Giglio N; Micone P; Gentile A
    Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus vaccine introduction in the Americas: progress and lessons learned.
    de Oliveira LH; Danovaro-Holliday MC; Matus CR; Andrus JK
    Expert Rev Vaccines; 2008 Apr; 7(3):345-53. PubMed ID: 18393604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the link between pneumococcal serotypes and invasive disease.
    Soley C; Arguedas A
    Vaccine; 2009 Aug; 27 Suppl 3():C19-21. PubMed ID: 19535183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of pneumococcal disease through vaccination.
    Gentile A; Bazán V
    Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct and indirect effects of the pneumococcal conjugated vaccine on carriage rates in children aged younger than 5 years in Latin America and the Caribbean: a systematic review.
    Silva SM; Rodrigues ICG; Santos RDS; Ternes YMF
    Einstein (Sao Paulo); 2020; 18():eRW4890. PubMed ID: 31778464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean.
    Whitney CG; Toscano CM
    Lancet Infect Dis; 2021 Mar; 21(3):306-308. PubMed ID: 32986995
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of pneumococcal conjugate vaccine into the Norwegian childhood vaccination programme.
    Bergsaker MA; Feiring B
    Euro Surveill; 2006 Feb; 11(2):E060202.5. PubMed ID: 16804205
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis.
    Sinha A; Constenla D; Valencia JE; O'Loughlin R; Gomez E; de la Hoz F; Valenzuela MT; de Quadros CA
    Rev Panam Salud Publica; 2008 Nov; 24(5):304-13. PubMed ID: 19141172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of Culture-Confirmed Pediatric Pneumococcal Pneumonia in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.
    Bardach AE; Rey-Ares L; Calderon Cahua M; Ciapponi A; Cafferata ML; Cormick G; Gentile Á
    Value Health Reg Issues; 2017 Dec; 14():41-52. PubMed ID: 29254541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.
    Madhi SA; Cohen C; von Gottberg A
    Vaccine; 2012 Sep; 30 Suppl 3():C21-7. PubMed ID: 22939016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.
    Yildirim I; Shea KM; Pelton SI
    Infect Dis Clin North Am; 2015 Dec; 29(4):679-97. PubMed ID: 26610421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
    Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence.
    Valenzuela MT; O'Loughlin R; De La Hoz F; Gomez E; Constenla D; Sinha A; Valencia JE; Flannery B; De Quadros CA
    Rev Panam Salud Publica; 2009 Mar; 25(3):270-9. PubMed ID: 19454155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccines for children: a global public health priority.
    Pittet LF; Posfay-Barbe KM
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():25-36. PubMed ID: 22862432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction.
    Garcia S; Levine OS; Cherian T; Gabastou JM; Andrus J;
    Rev Panam Salud Publica; 2006 May; 19(5):340-8. PubMed ID: 16805976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.